麻豆传媒

Drug might be most effective with a diuretic, according to suggestive data from a phase II trial

Randomized trial shows better outcomes for patients with acute coronary syndromes

First trial in a quarter-century to show mortality benefit in this desperately ill group

For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP

Patient acceptance could be an advantage, researchers say

Clinical benefit observed years after preventive PCI on non-flow-limiting plaque in PREVENT trial

Nonprescription rosuvastatin pans out in a second trial

Researcher suggests findings are robust enough to change practice guidelines

After ORBITA-COSMIC, Reducer device's mechanism of benefit remains unknown

HDL therapeutic failed to reduce risk of MI, stroke, or cardiovascular death in high-risk group

TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial

Standard medications losing appeal amid more modern heart attack treatments

Two trials show promise in moderate and extreme elevations

Two common devices go head to head in people with small aortic annuli